Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Federal Reserve Chairman Warsh: We are watching, but we try not to intervene.
2026-07-30
Federal Reserve Chairman Warsh: We are watching, but we try not to intervene.
Back
Other News
2026-07-30
The U.S. reserve requirement ratio as of July 30 was 3.65%, in line with expectations and unchanged from the previous value.
The U.S. reserve requirement ratio as of July 30 was 3.65%, in line with expectations and unchanged from the previous value.
2026-07-29
A circulated complaint alleges Kelun-Botai Biotech (06990.HK) and related personnel engaged in commercial bribery linked to its Lukang Shatuo monoclonal antibody. The complaint cites a 2025 list price of 9,399 yuan per vial and names hospitals includ
A circulated complaint alleges Kelun-Botai Biotech (06990.HK) and related personnel engaged in commercial bribery linked to its Lukang Shatuo monoclonal antibody. The complaint cites a 2025 list price of 9,399 yuan per vial and names hospitals including Beijing 301 and 307. Alleged inducements include cash kickbacks of 900–2,000 yuan per vial; foundation-anchored directed sponsorship and over 8 mln yuan in service fees to clinical directors; inflated meeting fees; and expensive gifts. Kelun-Botai said the claims are untrue, will verify the complainant and legal pursuit liability.
Chat with us
, powered by
LiveChat